<DOC>
	<DOCNO>NCT01517373</DOCNO>
	<brief_summary>This study understand efficacy safety investigational agent ( PF-04937319 ) compare approve agent ( glimepiride ) patient diabetes metformin</brief_summary>
	<brief_title>Study To Understand Efficacy And Safety Of Investigational Agent ( PF-04937319 ) Compared To Approved Agent ( Glimepiride ) In Patients With Diabetes On Metformin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Age 1870 yr , male female , T2DM , metformin alone combination 1 oral agent Subjects recent cardiovascular event , evidence diabetic complication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>T2DM</keyword>
	<keyword>PF-04937319</keyword>
	<keyword>Phase 2</keyword>
</DOC>